Quest Diagnostics Highlights Commitment to Healthcare Innovation at Upcoming Conference

Quest Diagnostics Strengthens Commitment to Healthcare Innovation

Quest Diagnostics Incorporated, a leading entity in diagnostic information services, is poised to spotlight its strategic growth and market evolution during an upcoming discussion led by its Executive Vice President and Chief Financial Officer, Sam Samad. Scheduled for March 11, 2026, at the Leerink 2026 Global Healthcare Conference in Miami, this session includes a Fireside Chat and Q&A segment. The conference offers key stakeholders insights into Quest's initiatives, emphasizing its ongoing commitment to providing superior healthcare solutions. Interested parties can tune in live via the company's investor relations website, with the option to access a replay within 24 hours of the event until March 25, 2026.

As a critical component of the U.S. healthcare system, Quest Diagnostics serves approximately half of the nation's physicians and hospitals and reaches over one-third of American adults each year. The company's mission revolves around enhancing healthcare by delivering smarter and simpler testing solutions. Through a robust framework that connects clinicians with vital laboratory insights, Quest is dedicated to improving health outcomes. This focus on diagnostic excellence positions Quest not merely as a service provider but as a proactive player in healthcare management, facilitating better patient care and disease prevention strategies.

Quest Diagnostics employs about 57,000 individuals who strive daily to provide diagnostic insights that drive actionable changes in healthcare. With an emphasis on innovation, the company consistently seeks to unveil new methods for disease identification and treatment, thereby fostering healthier behaviors and improving overall health management. Following the recent release of its fourth-quarter and full-year 2025 financial results, Duncan anticipates continued growth, backed by a 7.5% increase in its quarterly dividend, reflecting the company's solid performance and future prospects.

In tandem with its strategic objectives, Quest Diagnostics remains at the forefront of healthcare initiatives aimed at enhancing patient well-being and healthcare efficiency. The company’s commitment to improving diagnostic processes not only transforms lives but additionally supports its mission to be a leader in the industry.

For further inquiries and updates, individuals can visit www.QuestDiagnostics.com.